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Background: Experience in the use of whole slide imaging (WSI) for primary 
diagnosis is limited and there are no comprehensive reports evaluating this 
technology in liver biopsy specimens. 
Aims: To determine the accuracy of interpretation of WSI compared with 
conventional light microscopy (CLM) in the diagnosis of needle liver biopsies. 
Methods: Two experienced liver pathologists blindly analyzed 176 consecutive 
biopsies from the Pathology Department at the Hospital Clinic of Barcelona. 
One of the observers performed the initial evaluation with CLM, and the second 
evaluation with WSI, whereas the second observer performed the first 
evaluation with WSI and the second with CLM. All slides were digitized in a 
Ventana iScan HT at 400x and evaluated with the Virtuoso viewer (Roche 
diagnostics). We used kappa statistics (κ) for two observations.  
Results: Intra-observer agreement between WSI and CLM evaluations was 
almost perfect (96.6%, κ= 0.9; 95% confidence interval [95%CI]: 0.9-1 for 
observer 1, and 90.3%, κ= 0.9; 95%CI: 0.8-0.9 for observer 2). Both native and 
transplantation biopsies showed an almost perfect concordance in the 
diagnosis.  
Conclusion: Diagnosis of needle liver biopsy specimens using WSI is accurate. 
This technology can reliably be introduced in routine diagnosis. 
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observer agreement 
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INTRODUCTION 
Conventional light microscopy (CLM) has been the basic and, until 
recently, the only tool for the histological diagnosis of biopsy specimens. The 
development of the whole-slide Imaging (WSI) technology has started to 
change this picture in the last few years.  
The basis of the WSI technology is the use of high throughput scanners 
able to create high quality digital reproductions of glass slides containing a 
complete histological section and WSI viewers that allow navigation across the 
virtual slide. These tools enable the use of the computer as a CLM. WSI has 
many practical applications that include education and teleconsultation [1–4]. In 
the last few years the medical community has shown increasing interest in the 
use of WSI for routine primary diagnosis [5–7]. 
Indeed, routine pathological diagnosis can benefit from the advantages of 
this technology. The WSI workstations are more ergonomic and facilitate a 
more efficient sign-out process. WSI allows viewing several slides at the same 
time on the same screen, which is particularly helpful for the evaluation of 
immuno- or histochemically stained slides that can be analyzed together with 
hematoxylin-eosin (H&E) staining (Figure 1). The digital viewers incorporate 
tools that enable making annotations, rotating the images and making precise 
measurements [8]. WSI has a much larger field of vision than CLM and a wider 
range of magnifications, including very low magnifications that are very useful 
for the evaluation of surgical specimens. WSI facilitates sharing images and 
information with clinicians and other pathologists. This is not only extremely 
useful in tumors boards, but also allows expert tele-consultation of difficult 
cases and frozen section intra-operative biopsies [9,10]. Finally, with WSI 
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algorithms can be used for the evaluation and quantification of 
immuhistochemical stains, resulting in a more objective evaluation [11–14]. This 
tool is likely to become essential to achieve standardized diagnoses in the near 
future.  
Although WSI is considered to be comparable to CLM, adequate 
correlation between WSI and CLM diagnoses should be confirmed before this 
technology is used for primary diagnosis. The number of studies aimed at 
validating WSI in the routine diagnosis of the different areas of pathology is 
rapidly growing [15]. However, whereas relatively abundant information is 
available in some areas of pathology, validation studies are very scant or even 
absent in other areas, such as liver biopsy. Indeed, while a few studies have 
used this tool in research and automated image analysis [16–24], there is a 
complete absence of studies validating the use of WSI in needle liver biopsies, 
which may lead to reluctance in implementing this technology in routine 
diagnosis. 
MATERIALS AND METHODS  
Characteristics of the institution 
This study was performed at the Department of Pathology in the Hospital 
Clinic (Barcelona, Spain). This department is composed of 16 pathologists, 8 
residents and a variable number of fellows. The specimens are divided into 14 
subspecialties, and the pathologists limit their practice to one or two areas. In 
2015 the Department handled 43,678 specimens with 11,081 paraffin blocks. 
The number of liver needle biopsy specimens during this year was 230. The 
study was approved by the institutional ethics review board /HCB/2014/0514. 
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Sample size calculation 
The highest rate of discrepancy between the original diagnosis by CLM 
and that by WSI was calculated to be 3%, with a non-inferiority margin for WSI 
review of 5%. A 1-sided binomial test was used for comparison at a level of 
significance of .05. The power to be achieved was 70%, and the level of 
significance was .05. Based on these assumptions, it was calculated that 100 
cases would need to be reviewed to establish non-inferiority [25].  
Specimens included in the study 
All consecutive needle liver biopsy specimens received at the Department 
of Pathology of the Hospital Clinic in a 9-month period (February-October 2015) 
and assigned to the same expert pathologist were included in the study 
(n=176). This represented 76.5% of the total number of liver biopsies evaluated 
in 2015. All cases had a single paraffin block, containing one to five specimens 
(median 1). All specimens were routinely stained with H&E, Masson’s trichrome 
and reticulin stain. Additionally, immunohistochemical stains were used for 
specific cases after the request of the pathologist. The total number of scanned 
slides was 1286. The biopsies included both native and transplanted livers 
(n=112 and n=64, respectively). The median age of the patients was 57 years 
(range 18-91). 
Scanning process and characteristics of the WSI display 
All the needle liver biopsies were scanned daily after CLM diagnosis. The 
scanning of the histological slides was performed on a Ventana iScan HT 
(Ventana Medical Systems, Tucson, AZ, USA) at a magnification of 400x. The 
scanning process run automatically, and includes the selection of the area that 
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contains the tissue, the determination of the focus points, the calibration, and 
the scanning. When more than one section are mounted on a single slide, the 
system scans all the sections. No specific quality control of the slides scanned 
was made prior to evaluation by the pathologist. The WSI produced are stored 
in a dedicated mass storage environment and linked to the pathology report, 
based on the recognition of a QR code on the slide label. Although WSI can be 
accessed through the pathology laboratory information system (LIS) software 
(Novopath, Vitrosoft SL, Sevilla, Spain), for the purposes of this study access to 
the WSI was made through the viewer.  
The images were viewed with the Virtuoso viewer (Ventana), which works 
as a web browser and simulates a CLM. The images are shown using the same 
structure provided by the LIS. No specific software installation is required to 
visualize the WSI. The scanned images can be viewed up to a real 
magnification of 400x and up to 600x with a digital zoom, are always in focus, 
and have an optimized contrast and adjusted illumination. The viewer shows a 
thumbnail of the whole slide, which allows confirmation that all the material 
present on the glass slide has been included in the digital image and helps in 
the navigation through the slide. The WSI are displayed on a 30” Coronis fusion 
MDC4130 monitor which has a resolution of 4 Megapixels (Barco Electronic 
Systems, Barcelona, Spain). 
CLM and WSI diagnosis 
Two experts in liver pathology analyzed all cases. The first observer 
performed the initial evaluation with CLM, which was considered the reference 
for diagnostic attribution, and the second observation with WSI, whereas the 
second observer performed the initial evaluation with WSI and the second with 
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CLM. In order to avoid interference with the first diagnosis, the minimum 
washout period between the two observations was 1.5 months (range 1.5-4 
months). All the histological slides of each case were scanned and evaluated. A 
summary with the basic original clinical information was provided to the 
pathologist in both evaluations in order to emulate the real clinical environment, 
and the pathologist could also request additional information. When performing 
the WSI, the pathologist was blinded to the original diagnostic report, as well as 
to the evaluation made by the other pathologist. In all cases, a main diagnosis 
was rendered in both evaluations. Additionally, in some specimens additional 
secondary diagnoses were also provided. 
Concordance between CLM and WSI diagnosis and features evaluated  
An independent pathologist not involved with the evaluation compared the 
original CLM and the WSI-based evaluations and judged the concordance of 
the two diagnoses. Concordance was classified as: a) complete agreement; b) 
minor discrepancy (slight differences which would not have any clinical or 
prognostic implications); and c) major discrepancy (differences with clinical 
and/or prognostic implications for the patient).  
Some histological features were routinely evaluated in all the specimens: 
portal fibrosis (using a 0-4 scale), presence or absence of Mallory-Denk bodies, 
steatosis (using a 0-3 scale), and liver cell ballooning [26,27]. Portal 
inflammation, cholangitis and endothelitis were estimated using a 0-3 scale in 
all the acute rejection biopsies [28]. In the cases of cirrhosis and chronic 
hepatitis, necro-inflammatory activity (portal/periportal and lobular) was 
evaluated with a 0-3 scale [29–32]. Other characteristics were recorded when 
present. 
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Statistical analysis 
The SPSS (SPSS IncTM140, Version 18, Chicago, IL, USA) was used for 
statistical analyses. The results for categorical variables are expressed as 
absolute numbers and percentages and 95% confidence intervals (95%CI). The 
Chi-squared or the Fisher's exact tests were used to compare the variables. 
The results were evaluated by unweighted Kappa statistics for two 
observations. This measure calculates the degree of agreement in classification 
over that which would be expected by chance and is scored as a number 
between 0 and 1. According to the Landis-defined categories the strength of 
agreement of the Kappa values (κ) is: 0 none, beyond chance; 0-0.20 slight; 
0.21-0.40 fair; 0.41-0.60 moderate; 0.61-0.80 substantial; 0.81-1.00 almost 
perfect. For the kappa value calculation, the main diagnoses were grouped into 
nine categories for the native livers and six categories for the transplanted 
livers. The diagnostic categories for the native livers included: a) slight changes 
(including isolated steatosis), b) venous congestion, c) autoimmune diseases 
(autoimmune hepatitis and primary biliary cirrhosis), d) steatohepatitis, e) acute 
hepatitis, f) chronic viral hepatitis g) cirrhosis, h) malignant tumors (primary or 
metastatic), and i) other diseases. The diagnostic categories for the 
transplanted livers included: a) slight changes; b) autoimmune hepatitis, c) 
steatohepatitis, d) hepatitis C virus infection, e) acute cellular rejection, and f) 
chronic rejection. 
RESULTS  
Intra-observer and inter-observer agreement 
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The overall intra-observer agreement between the CLM and the WSI 
diagnoses was 96.6% (κ= 0.9; 95% CI: 0.9-1) for the observer 1 and 90.3% (κ= 
0.9; 95% CI: 0.8-0.9) for the observer 2. There were four minor discrepancies 
between the CLM and the WSI diagnoses for observer 1 and 14 for observer 2. 
None of the discrepancies were related to a poor quality of the WSI image or to 
insufficient magnification. The diagnoses of carcinoma showed 100% 
concordance in all four evaluations. The overall inter-observer agreement 
between the CLM diagnoses performed by observer 1 and 2 was 92.6% (κ= 
0.9; 95% CI: 0.9-1) and 96.6% (κ= 1; 95% CI: 0.9-1) for the WSI diagnoses. 
The intra-observer agreement between CLM and WSI for the native liver 
biopsies (n= 112) was 95.5% (κ= 0.9; 95% CI: 0.9-1) for observer 1 and 90.2% 
(κ= 0.9; 95% CI: 0.8-0.9) for observer 2. The inter-observer agreement between 
the CLM diagnoses performed by observer 1 and 2 was in this group of native 
liver biopsies was 92.9% (κ= 0.9; 95% CI: 0.9-1) and 87.5% (κ= 0.9; 95% CI: 
0.8-0.9) for the WSI diagnoses. Table 1 shows the intra-observer (WSI vs. 
CLM) for the two observers and the inter-observer agreement for CLM and WSI 
for each specific diagnostic group for the 112 native liver specimens. 
Table 2 shows the intra-observer (WSI vs. CLM) for the two observers and 
the inter-observer agreement for CLM and WSI for each specific diagnostic 
group for the 64 transplantation biopsies. The intra-observer agreement 
between CLM and WSI for the transplanted liver biopsies was 93.7% (κ= 0.9; 
95% CI: 0.8-1) for observer 1 and 87.5% (κ= 0.8; 95% CI: 0.7-0.9) for observer 
2. The inter-observer agreement between the CLM diagnoses performed by 
observer 1 and 2 was in this group of transplanted liver biopsies was 89.1% (κ= 
0.8; 95% CI: 0.7-1) and 87.5% (κ= 0.8; 95% CI: 0.7-0.9) for the WSI diagnoses. 
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Agreement between WSI and CLM in relevant liver changes 
Table 3 shows the intra-observer (WSI vs. CLM) and the inter-observer 
(WSI vs. WSI and CLM vs. CLM) agreement in the evaluation of relevant 
histological features in the native livers (steatosis, liver cell ballooning, presence 
or absence or Mallory-Denk bodies, portal/peri-portal inflammatory activity and 
necrosis and lobular necrosis and inflammatory activity). Table 4 shows the 
intra-observer (WSI vs. CLM) and the inter-observer (WSI vs. WSI and CLM vs. 
CLM) agreement in the evaluation of major histological features in transplanted 
livers (portal inflammation, cholangitis and endothelitis).  
DISCUSSION  
This is the first study evaluating the accuracy of WSI diagnosis in the 
routine practice of needle liver biopsies. Our results show a high intra-observer 
concordance between the CLM and the WSI evaluations (over 90% for both 
obseervers) in the diagnoses of a large series of routine needle liver specimens. 
The kappa value, considered as a measure of the level of intra- and inter-
observer agreement corrected by chance, was almost perfect (0.9 for both 
observers) and 0.9-1 for the inter-oberver comparisons of the CLM and the WSI 
evaluations. The percentage of discrepancies between the CLM and WSI 
diagnoses observed in our study was below 10%, and only minor discrepancies 
were identified. Neither had an impact on patient management. More 
importantly, none of the discrepancies was related to a poor quality of the WSI 
image or to insufficient magnification. All the discrepancies observed were 
associated with either the small size of the material or to the intrinsic difficulty of 
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the case. Thus, our results confirm that WSI may confidently be used for 
primary histological diagnosis of liver biopsies.  
A number of studies have shown that there is a substantial variation 
between and within observers in the evaluation of liver biopsy specimens. 
These studies are limited to specific diseases such as non-alcoholic 
steatohepatitis and chronic viral hepatitis [33–37]. In an intra-observer 
concordance study including 50 biopsies oriented as non-alcoholic 
steatohepatitis Kleiner et al reported a kappa value of 0.61 [34]. Our study 
showed a higher rate of concordance in the evaluation of steatohepatitis with a 
kappa value ranging from 0.7 to 0.9 in the different comparisons, although the 
number of cases with this diagnosis was much lower and included both 
alcoholic and non-alcoholic steatohepatitis. Three studies have evaluated intra-
observer concordance in the diagnosis of chronic viral hepatitis. The evaluation 
of fibrosis grade and stage in these studies showed kappa values ranging from 
0.72 and 1 [35–37], which were comparable with the concordance rates 
observed in our study (0.7 to 0.9). These discrepancies have mainly been 
attributed to the inherent intra-observer variability in the diagnosis of needle 
liver biopsy specimens. Interestingly, some of these studies analyzed a number 
of histological features separately, showing high concordance rates for steatosis 
(κ = 0.79), periportal necrosis (κ = 0.74) and fibrosis (κ = 0.86) and lower values 
for lobular necrosis (κ= 042) [33,34]. In the present study, the concordance 
observed for all these histological findings showed even better results. A 
possible limitation of our study is the lower number of cases of each particular 
disease included in the analysis compared to previous reports [33–37]. 
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However, our study was designed to evaluate the reliability of the WSI tool for 
the diagnosis of any liver lesion and not specifically for a single disease. 
Interestingly, the specific analysis of liver transplantation specimens 
(n=64) showed a high intra-observer concordance that remained almost perfect 
(93.7%; κ= 0.9 for observer 1, 87.5, κ= 0.8 for observer 2). There were no 
differences in the diagnosis of rejection.  
The results obtained in our study with the liver biopsies are comparable to 
other validation studies conducted in other areas of pathology, such as breast 
[38], skin [39], gastrointestinal [40,41], prostate [42–46], gynecological [25], 
renal [46,47] or pediatric pathology [48,49] which show similar high rates of 
concordance between CLM and WSI diagnoses. Thus, the results of all these 
studies indicate that WSI should be considered as a validated tool, almost 
equivalent to the CLM. In keeping with this assumption, the guidelines and 
recommendations of the College of American Pathologists, the Canadian 
Association of Pathologists and the American Telemedicine Association for 
adequate validation of WSI before its use in routine diagnosis do not require a 
validation for each specific area [1,4]. These recommendations indicate that 
only 60 samples per pathologist should be evaluated in order to ensure the 
familiarity of the pathologist with the new tool. Indeed, as with any other tool, 
there is a learning curve for WSI [25,50–54]. 
Remarkably, the pathologist did not report any difficulty in rendering the 
diagnosis at the magnification used in this study (400x). A 200x magnification is 
considered as appropriate to achieve a correct diagnosis in most previously 
published studies evaluating other areas of pathology [25,42,48,50,55–57]. 
However, this scanning magnification may not be sufficient for some areas, 
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such as the liver due to the small size of the specimens and the need to 
evaluate subtle changes that frequently require the use of high magnification.  
The introduction of the WSI technology may significantly improve the 
diagnosis of routine needle liver biopsy specimens taking into account the 
advantage of the possibility of viewing multiple slides at the same time with this 
technique. Indeed, this advantage can be very useful in liver pathology since 
several stains are often used and WSI facilitates tele-consultation. Finally, the 
future development of computer-assisted diagnostic algorithms is likely to help 
reduce intra- and inter-observer variability. However, many issues should be 
addressed to make this implementation feasible and cost-efficient, such as the 
cost of the scanners [4,8,58–61], the costs associated with the maintenance of 
the system and the storage of the images and legal issues related to the use of 
WSI for primary diagnosis, including image storage and patient confidentiality. 
Approval is currently being sought from the US Food and Drug Administration 
(FDA) for the use of WSI in primary diagnosis. In the meantime, WSI is being 
increasingly used in several centers around the world. 
In conclusion, the diagnosis of needle liver biopsies using WSI has high 
intra-observer concordance with the results of CLM evaluation. Our results 
confirm that WSI can be safely used for primary histological diagnosis of liver 
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FIGURE LEGEND  
Figure 1. The WSI viewer may simultaneously show and synchronously move 
several slides of a case. This is particularly helpful in the evaluation of liver 
biopsy specimens since it allows the analysis of an H&E stained slide together 
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Table 1: Intra-observer (whole slide imaging [WSI] vs. conventional light microscopy [CLM]) for the two observers and Inter-





























Mild changes * 22 98.3 0.9  (0.9-1) 94.9 0.9 (0.8-0.9) 96.0 0.9 (0.8-1) 96.0 0.9 (0.8-1) 
Venous 
congestion  
4 100 1 (NA) 98.9 0.9 (0.5-1) 98.3 0.7 (0.4-1) 99.4 0.9 (0.7-1) 
Autoimmune 
diseases # 
15 99.4 1 (0.9-1.0) 98.3 0.9 (0.8-1) 98.9 0.9 (0.8-1) 97.7 0.9 (0.7-1) 
Steatohepatitis 12 98.3 0.9 (0.8-1) 97.7 0.8 (0.7-1) 97.7 0.8 (0.7-1) 96.0 0.7 (0.6-0.9) 
Acute hepatitis & 7 99.4 0.9 (0.8-1) 98.3 0.8 (0.6-1) 99.4 0.9 (0.8-1) 98.3 0.8 (0.6-1) 
Chronic 
hepatitis ** 
14 97.7 0.9 (0.9-1) 94.9 0.8 (0.7-0.9) 97.7 0.9 (0.9-1) 93.7 0.8 (0.7-0.9) 
Cirrhosis  19 100 1 (NA) 100  1 (NA) 98.9 0.9 (0.8-1) 98.9 0.9 (0.8-1) 
Tumors ## 14 100 1 (NA) 100 1 (NA) 100 1 (NA) 100 1 (NA) 
Other && 5 100 1 (NA) 98.9 0.8 (0.6-1) 99.4 0.9 (0.8-1) 99.4 0.9 (0.8-1) 
95%CI: 95% confidence interval; * includes mild to moderate macrovesicular steatosis (n=15) and mild non-specific changes (n=7); # 
includes autoimmune hepatitis (7 cases) and primary biliary cirrhosis (8 cases); & includes four toxic acute hepatitis, two acute B hepatitis 
and one hepatitis of unknown origin; ** includes 10 chronic hepatitis C, two chronic hepatits B and two drug induced hepatitis; ## includes 
one cholangiocarcinoma, six metastatic carcinomas, six hepatocellular carcinomas and one hemangioma; && includes one case each of 
schistosomiasis, cystic fibrosis, graft versus host disease, sclerosing cholangitis and nodular regenerative hyperplasia. NA: not applicable 
Table 2: Intra-observer (whole slide imaging [WSI] vs. conventional light microscopy [CLM]) for the two observers and Inter-
observer agreement for CLM and WSI in the diagnosis of liver transplantation biopsies (n=64). 




























































































95%CI: 95% confidence interval; NA: not applicable; * hepatitis C virus reinfection; # Includes one case of preservation injury and 
one insufficient biopsy 
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Table 3: Intra-observer (whole slide imaging [WSI] vs. conventional light microscopy [CLM]) for the two observers and Inter-
observer agreement for CLM and WSI in the evaluation of major histological changes in the native livers (n=112). 



































































Lobular necrosis and 









95%CI: 95% confidence interval; * Graded on a 0-4 scale; # Graded on a 0-3 scale; # Evaluated as absent or present;  ** Portal/peri-portal 
inflammatory activity and necrosis and lobular necrosis and inflammatory activity were evaluated only in the cases with a diagnosis of 
cirrhosis (n=19) and chronic hepatitis (14 in native livers and 20 in transplanted livers) 
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Table 4: Intra-observer (whole slide imaging [WSI] vs. conventional light microscopy [CLM]) for the two observers and Inter-

























































95%CI: 95% confidence interval; All features were graded on a 0-3 scale. 
 
